Table 2.
Clone | Recombinant protein | ||||||||
---|---|---|---|---|---|---|---|---|---|
Phl p 1 (negative control) | Phl p 5.0101 | Phl p 5.0201 | Phl p 6.0101 | Phl p 5.0201 C-terminal domain*,† | |||||
Wild-type | Mutations 1-6 | Mutations 1 + 10 | Mutations 1-6, 10 | Mutations 7-10 | |||||
4.3 | −‡ | +++ | ++ | +++ | − | − | − | − | − |
4.12 | − | +++ | ++ | − | − | − | − | ++ | − |
p5-MA5 | − | +++ | +++ | − | ++ | +++ | + | +++ | − |
p5-AB5 | − | +++ | +++ | − | + | +++ | ++ | +++ | − |
The following mutations in the C-terminal domain of Phl p 5.0201 were investigated: mutation number 1: K149A; 2: K160A; 3: K166A; 4: K190A; 5: K193A; 6: K204A; 7: K214A; 8: K238A; 9: K248A; 10: K283A.
Residues 214, 238 and 248 (modified by mutations 7-9) in Phl p 5.0201 correspond to residues 246, 270 and 280 in Phl p 5.0101 (Figure2A).
Absorbance values: −: A450 = 0–0.5; +: A450 = 0.5–1; ++: A450 = 1–2; +++: A450 = 2–3.